Makiyama A - Search Results

1

Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study.

Shiroyama M, Fukuoka S, Masuishi T, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Shimada Y, Esaki T, Makiyama A, Moriwaki T. Shiroyama M, et al. Among authors: makiyama a. Sci Rep. 2023 Oct 20;13(1):17931. doi: 10.1038/s41598-023-45244-7. Sci Rep. 2023. PMID: 37863951 Free PMC article.

2

Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines.

Makiyama A, Qin B, Uchino K, Shibata Y, Arita S, Isobe T, Hirano G, Kusaba H, Baba E, Akashi K, Nakano S. Makiyama A, et al. Anticancer Drugs. 2009 Feb;20(2):123-30. doi: 10.1097/CAD.0b013e3283218080. Anticancer Drugs. 2009. PMID: 19209029

3

Phase 2 study of modified irinotecan and bolus 5-fluorouracil/l-leucovorin in Japanese metastatic colorectal cancer patients.

Baba E, Fujishima H, Makiyama A, Uchino K, Tanaka R, Esaki T, Kusaba H, Mitsugi K, Nakano S, Akashi K. Baba E, et al. Among authors: makiyama a. Adv Ther. 2012 Mar;29(3):287-96. doi: 10.1007/s12325-012-0002-3. Epub 2012 Feb 10. Adv Ther. 2012. PMID: 22351434 Clinical Trial.

4

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours.

Seto T, Esaki T, Hirai F, Arita S, Nosaki K, Makiyama A, Kometani T, Fujimoto C, Hamatake M, Takeoka H, Agbo F, Shi X. Seto T, et al. Among authors: makiyama a. Cancer Chemother Pharmacol. 2013 Sep;72(3):619-27. doi: 10.1007/s00280-013-2234-6. Epub 2013 Jul 28. Cancer Chemother Pharmacol. 2013. PMID: 23892959 Clinical Trial.

5

Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases.

Nakano M, Kusaba H, Makiyama A, Ariyama H, Arita S, Oda H, Esaki T, Takayoshi K, Uchino K, Tamura S, Kumagai H, Iwama E, Shirakawa T, Mitsugi K, Takaishi S, Akashi K, Baba E. Nakano M, et al. Among authors: makiyama a. Anticancer Res. 2014 Jan;34(1):215-20. Anticancer Res. 2014. PMID: 24403465

6

Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in Japan.

Hirano G, Makiyama A, Makiyama C, Esaki T, Oda H, Uchino K, Komoda M, Tanaka R, Matsushita Y, Mitsugi K, Shibata Y, Kumagai H, Arita S, Ariyama H, Kusaba H, Akashi K, Baba E. Hirano G, et al. Among authors: makiyama c, makiyama a. Anticancer Res. 2015 Jan;35(1):371-7. Anticancer Res. 2015. PMID: 25550574

7

Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy.

Nio K, Arita S, Isobe T, Kusaba H, Kohashi K, Kajitani T, Tamura S, Hirano G, Mitsugi K, Makiyama A, Esaki T, Ariyama H, Oda Y, Akashi K, Baba E. Nio K, et al. Among authors: makiyama a. Cancer Chemother Pharmacol. 2015 Apr;75(4):829-35. doi: 10.1007/s00280-015-2706-y. Epub 2015 Feb 22. Cancer Chemother Pharmacol. 2015. PMID: 25702050

8

Efficacy and Safety of TAS-102 in Clinical Practice of Salvage Chemotherapy for Metastatic Colorectal Cancer.

Arita S, Shirakawa T, Matsushita Y, Shimokawa HK, Hirano G, Makiyama A, Shibata Y, Tamura S, Esaki T, Mitsugi K, Ariyama H, Kusaba H, Akashi K, Baba E. Arita S, et al. Among authors: makiyama a. Anticancer Res. 2016 Apr;36(4):1959-66. Anticancer Res. 2016. PMID: 27069187

9

Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric Cancer.

Inadomi K, Kusaba H, Matsushita Y, Tanaka R, Mitsugi K, Arimizu K, Hirano G, Makiyama A, Ohmura H, Uchino K, Hanamura F, Shibata Y, Kuwayama M, Esaki T, Takayoshi K, Arita S, Ariyama H, Akashi K, Baba E. Inadomi K, et al. Among authors: makiyama a. Anticancer Res. 2017 May;37(5):2663-2671. doi: 10.21873/anticanres.11614. Anticancer Res. 2017. PMID: 28476842 Clinical Trial.

10

Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.

Takayoshi K, Kusaba H, Uenomachi M, Mitsugi K, Makiyama C, Makiyama A, Uchino K, Shirakawa T, Shibata Y, Shinohara Y, Inadomi K, Tsuchihashi K, Arita S, Ariyama H, Esaki T, Akashi K, Baba E. Takayoshi K, et al. Among authors: makiyama c, makiyama a. Cancer Chemother Pharmacol. 2017 Aug;80(2):333-342. doi: 10.1007/s00280-017-3371-0. Epub 2017 Jun 26. Cancer Chemother Pharmacol. 2017. PMID: 28653251 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page